Study Summary
The purpose of this study is to evaluate the safety and efficacy of CAR T cell treatment targeting CD7 in patients with relapsed or refractory CD7 positive T-cell hematological maliganacies
Want to learn more about this trial?
Request More InfoInterventions
anti-CD7 CAR-T cellsDRUG
Administration with anti-CD7 CAR-T cells in the relapsed/refractory T cell hematological malignancy patients
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Xianmin General Song | Shanghai | China |